New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
16:22 EDTVMW, YUM, AGN, MCD, EMC, EXTR, MNST, VRXOn The Fly: Closing Wrap
Stocks on Wall Street began the trading day in negative territory and remained there through nearly the whole session. The market action was influenced more by the geopolitical events in Russia and Israel than by the upcoming avalanche of earnings scheduled for release throughout the week. Despite the weak open and subsequent drop during the first hour of trading, the market drifted off its lows and managed to pare its losses, even turning mixed for a short time. The averages dipped again heading into the bell, though they closed well of their worst levels. ECONOMIC EVENTS: In the U.S., the Chicago Fed's National Activity Index dipped to 0.12 in June from a reading of 0.16 in May. COMPANY NEWS: Allergan (AGN) rose $3.74, or 2.23%, to $171.14 after the company's Q2 results and its FY14 outlook beat expectations. The company, which is working to fend off a proposed acquisition by Valeant Pharmaceuticals (VRX), also announced plans to cut its workforce by 13%, or about 1,500 employees, as part of a broader restructuring effort. In related news, Valeant announced it has contacted both the SEC and Canadian financial authorities regarding Allergan's "apparent attempt to mislead investors and manipulate the market for Valeant common shares by continuing to make false and misleading statements regarding Valeant's business." Later in the day, Bill Ackman of Pershing Square, who is partnering with Valeant in its attempt to buy Allergan, called the restructuring a "Valeant light" effort and said Valeant does not need to raise its bid for Allergan. Ackman explained that he believes that shares of Valeant will rise around $10 should the Allergan board engage in takeover talks with the company and that a $10 share rise would boost Valeant's bid for Allergan by $8 per share. MAJOR MOVERS: Among the notable gainers was Extreme Networks (EXTR), which rose 69c, or 15.79%, to $5.06 after the company raised its Q4 earnings per share outlook and narrowed its Q4 revenue view. Also higher were shares of EMC (EMC), which advanced $1.35, or 5.0%, to $28.33 after the Wall Street Journal reported, citing sources, that activist investor Elliott Management has taken a stake of over $1B in the data-storage company and plans to push it to break itself up and spin off VMware (VMW), which is 80% owned by EMC. Shares of VMware fell $2.36, or 2.48%, to $92.95 following the Journal's report. Among the other noteworthy losers was Monster Beverage (MNST), which fell $3.07, or 4.53%, to $64.74 after Morgan Stanley downgraded the stock, citing slowing U.S. trends and balanced valuation. Also lower were shares of Yum! Brands (YUM), which fell $3.29, or 4.25%, to $74.13 after Associated Press reported that the company's KFC brand and McDonald's (MCD) were sold expired beef and chicken in China from food supplier Husi Food. Shares of McDonald's, which is scheduled to report on its quarter before tomorrow's market open, slid $1.44, or 1.45%, to $97.55. INDEXES: The Dow fell 48.45, or 0.28%, to 17,051.73, the Nasdaq dropped 7.44, or 0.17%, to 4,424.70, and the S&P 500 declined 4.59, or 0.23%, to 1,973.63.
News For AGN;VRX;EMC;YUM;MNST;MCD;VMW;EXTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 31, 2015
07:39 EDTAGNCiti calls Allergan a 'stock to own,' keeps $360 target
Citi analyst Liav Abraham calls Allergan a "stock to own" given its "attractive" organic growth profile, pipeline potential and ability to do more acquisitions. He reiterates a Buy rating on the stock with a $360 price target.
06:31 EDTVMWVMware to host financial analyst day
Subscribe for More Information
August 30, 2015
12:33 EDTMCDDividend-rich blue chips look attractive amid market volatility, Barron's says
Subscribe for More Information
August 28, 2015
09:50 EDTAGNAllergan plans for generic version of Endo's Fortesta blocked, Bloomberg reports
A judge upheld Endo's (ENDP) patents on Fortesta expiring in 2018 and blocked Allergan's (AGN) bid to launch a generic version of the testosterone gel, according to Bloomberg.
August 27, 2015
19:53 EDTMCDMcDonald's, Tyson Foods drop T&S Farm after animal cruelty video, Reuters says
McDonald's (MCD) and Tyson Foods (TSN) terminated a contract with T&S Farm after animal rights activists shot an undercover video showing farm workers engaging in "unacceptable animal treatment", reports Reuters citing Tyson spokesman Worth Sparkman and a statement from McDonald's. Reference Link
18:16 EDTYUM, MCDLabor Relations Board revises joint employer policy
Subscribe for More Information
August 26, 2015
16:26 EDTVMW, EMCOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
16:12 EDTVMWVMware names Ray O'Farrell Chief Technology and Development Officer
Subscribe for More Information
15:27 EDTVMW, EMCVMware falls after report EMC board weighing downstream merger proposal
Subscribe for More Information
12:47 EDTVMW, EMCOn The Fly: Top stock stories at midday
Subscribe for More Information
12:08 EDTVMW, EMCEMC Federation departures suggest changes coming, says Raymond James
Subscribe for More Information
11:50 EDTVMW, EMCEMC-VMware report shows board knows status quo 'not an option,' says Wells Fargo
After Re/code's Arik Hesseldahl reported that EMC's (EMC) board is "actively considering" a downstream merger proposal under which it would be acquired by VMware (VMW), Wells Fargo analyst Maynard Um said he views the most important takeaway to be that the board views maintaining the status quo as "not an option" amid the rapid shift in the industry. Um thinks an EMC buy-in of VMware, which the report contends is the preferred option of EMC CEO Joe Tucci, presents a cleaner path with less variables but says that in either case it "seems clear that something will happen," which he views as a positive.
09:25 EDTEMCOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Abercrombie & Fitch (ANF), down 15.1%... Express (EXPR), up 9.8%... Frontline (FRO), up 10.4%... Chico's FAS (CHS), up 9.3%. ALSO HIGHER: Oshkosh (OSK), up 11.9% after being awarded a $6.7B contract by the U.S. Army... EMC Corporation (EMC), up 5.8% after Re/code reported that the board is considering a VMware (VMW) downstream merger proposal... Google (GOOG), up 4.6% after being upgraded to Conviction Buy from Neutral at Goldman... Ford (F), up 2.4% after Bloomberg reported that the company is considering returning production of Bronco and Ranger to the U.S. NOTABLE: Cameron International (CAM), up 45.4% after announcing that it will be acquired by Schlumberger (SLB). Schlumberger is down 1.9%. LOWER: WisdomTree (WETF), down 3.6% after being downgraded to Sell from Buy at Citi... Transocean (RIG), down 3.4% after proposing to cancel Q3 and Q4 dividends.
08:23 EDTEMC, VMWEMC board 'considering' VMware downstream merger proposal, Re/code reports
Subscribe for More Information
07:01 EDTEMCNimble Storage reported another 'solid' quarter, says Summit Research
Summit Research analyst Srini Nandury called Nimble Storage's (NMBL) quarterly results "solid," highlighting the company's report of strong demand, higher deal sizes and addition of an all-time high 690 new customers. The firm, which said it expects Nimble to gain share from both EMC (EMC) and NetApp (NTAP) "in short order," reiterates its Buy rating and $40 price target on Nimble shares.
06:18 EDTMCDMcDonald's customization kiosks fail to reach drive-thru customers, QSR reports
McDonald's' new "Create Your Taste" kiosks in all its franchises, allowing for customers to customize their orders, may present a problem since they can only be accessed from inside the restaurants, and McDonald's allegedly receives as much as 70% of its sales from the drive-thru, QSR Magazine reports. The expensive new kiosks are expected to cost franchises between $100,000-$150,000 to install, the report says. "At a cost of $100,000-$150,000 per restaurant to implement, it has a limited upside," Richard Adams, a former McDonald's franchisee, told QSR. "I think this is more a stunt to appeal to Wall Street investors instead of being practical for the restaurant operator." Reference Link
August 25, 2015
08:35 EDTVMW, EXTRExtreme Networks joins VMware NSX partner ecosystem
Subscribe for More Information
08:14 EDTAGNAllergan multiple is low, says Leerink
Leerink predicts that Allergan's 2016 EPS will come in at $17-$18. The firm thinks the company has "durable revenue streams," and a "deep pipeline with several potential blockbuster candidates." Leerink adds that the company "has significant capacity for M&A." It keeps a $388 price target and Outperform rating on the shares.
08:05 EDTVRXValeant names D. Robert Hale to board of directors
Valeant Pharmaceuticals International announced the addition of D. Robert Hale, Partner of ValueAct Capital, to its board of directors and the resignation of Jeffrey W. Ubben, CEO and CIO of ValueAct Capital, effective as of August 19, 2015. ValueAct Capital, an investment firm based in San Francisco with over $20B under management, owns approximately 4% of the outstanding stock of Valeant, and has been a shareholder in Valeant since 2006. As a Partner and member of the investment team of ValueAct Capital, Hale has worked closely with the board and management team of Valeant since January 2011. Hale will be the fourth Partner of ValueAct Capital to serve on the Valeant Board, following Mason Morfit, Brandon Boze, and Jeff Ubben.
August 24, 2015
08:37 EDTAGNAllergan recalls certain lots of REFRESH, FML, Blephamide treatments
Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its REFRESH Lacri-Lube 3.5g and 7g for dry eye, REFRESH P.M. 3.5g for dry eye, FML 0.1%, and Blephamide 10%/0.2% sterile topical ophthalmic ointment combining an antibacterial and a corticosteroid, 3.5g. Allergan chose to initiate this recall based on a small number of customer complaints which reported a small black particle at the time of use. Allergan has informed the U.S. Food and Drug Administration of this voluntary recall. Allergan is contacting retailers and wholesalers who have been shipped affected product lots to initiate the recall and is informing them of the steps needed to return affected product.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use